Jean-Michel Auger

Title: Jean-Michel Auger: Innovator in Antibiotic Development

Introduction

Jean-Michel Auger is a notable inventor based in Montreuil, France. He has made significant contributions to the field of medicine, particularly in the development of antibiotic compounds. His work has implications for the treatment of various bacterial infections.

Latest Patents

Jean-Michel Auger holds a patent for "6-deoxy erythromycin derivatives, method for preparing same and use as medicines." This invention concerns compounds of formula (I) wherein: X represents a (NH)a, CH or SO radical or an oxygen atom; a represents 0 or 1; Y represents a (CH)m-(CH=CH)n-(CH)o radical with m+n+o≤8, n=0 or 1; Ar represents an aryl or heteroaryl radical, optionally substituted; W represents a hydrogen atom or a halogen atom; Z represents a hydrogen atom or an acid residue, and their addition salts with acids. The compounds of formula (I) have antibiotic properties, showcasing the potential for new treatments in medicine.

Career Highlights

Jean-Michel Auger is associated with Aventis Pharma S.A., where he has been instrumental in research and development. His work focuses on creating innovative solutions to combat bacterial infections through antibiotic research. His dedication to advancing medical science is evident in his patent and ongoing research efforts.

Collaborations

Jean-Michel Auger has collaborated with Alexis Denis, contributing to the advancement of antibiotic research and development. Their partnership highlights the importance of teamwork in achieving significant breakthroughs in the pharmaceutical industry.

Conclusion

Jean-Michel Auger is a prominent figure in the field of antibiotic development, with a patent that underscores his innovative contributions. His work at Aventis Pharma S.A. and collaboration with fellow researchers exemplify the ongoing efforts to improve medical treatments.